Literature DB >> 21544310

Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).

R A Pixley1, R G Espinola, B Ghebrehiwet, K Joseph, A Kao, K Bdeir, D B Cines, R W Colman.   

Abstract

The physiologic activation of the plasma kallikrein-kinin system requires the assembly of its constituents on a cell membrane. High- molecular-weight kininogen (HK) and cleaved HK (HKa) both interact with at least three endothelial cell binding proteins: urokinase plasminogen activator receptor (uPAR), globular C1q receptor (gC1qR,) and cytokeratin 1 (CK1). The affinity of HK and HKa for endothelial cells are KD=7-52 nM. The contribution of each protein is unknown. We examined the direct binding of HK and HKa to the soluble extracellular form of uPAR (suPAR), gC1qR and CK1 using surface plasmon resonance. Each binding protein linked to a CM-5 chip and the association, dissociation and KD (equilibrium constant) were measured. The interaction of HK and HKa with each binding protein was zinc-dependent. The affinity for HK and HKa was gC1qR>CK1>suPAR, indicating that gC1qR is dominant for binding. The affinity for HKa compared to HK was the same for gC1qR, 2.6-fold tighter for CK1 but 53-fold tighter for suPAR. Complex between binding proteins was only observed between gC1qR and CK1 indicating that a binary CK1-gC1qR complex can form independently of kininogen. Although suPAR has the weakest affinity of the three binding proteins, it is the only one that distinguished between HK and HKa. This finding indicates that uPAR may be a key membrane binding protein for differential binding and signalling between the cleaved and uncleaved forms of kininogen. The role of CK1 and gC1qR may be to initially bind HK to the membrane surface before productive cleavage to HKa.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544310      PMCID: PMC3149827          DOI: 10.1160/TH10-09-0591

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  45 in total

1.  Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.

Authors:  R W Colman; B A Jameson; Y Lin; D Johnson; S A Mousa
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells.

Authors:  Anthony N Fernando; Lawrence P Fernando; Yu Fukuda; Allen P Kaplan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07       Impact factor: 4.733

3.  Identification of an endothelial cell binding site on kininogen domain D3.

Authors:  H Herwald; A A Hasan; J Godovac-Zimmermann; A H Schmaier; W Müller-Esterl
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

Review 4.  Structure and function of gC1q-R: a multiligand binding cellular protein.

Authors:  B Ghebrehiwet; E I Peerschke
Journal:  Immunobiology       Date:  1998-08       Impact factor: 3.144

5.  The contact system: a proinflammatory pathway with antithrombotic activity.

Authors:  R W Colman
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

6.  Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).

Authors:  K Joseph; B Ghebrehiwet; E I Peerschke; K B Reid; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.

Authors:  H N Bradford; B A Jameson; A A Adam; R P Wassell; R W Colman
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.

Authors:  A A Hasan; D B Cines; J Zhang; A H Schmaier
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

9.  Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.

Authors:  Dian J Cao; Yan-Lin Guo; Robert W Colman
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

10.  A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat.

Authors:  James C Keith; Irma M Sainz; Irma Isordia-Salas; Robin A Pixley; Yelena Leathurby; Leo M Albert; Robert W Colman
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

View more
  16 in total

1.  High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.

Authors:  Aizhen Yang; Jihong Dai; Zhanli Xie; Robert W Colman; Qingyu Wu; Raymond B Birge; Yi Wu
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

2.  Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.

Authors:  Venkaiah Betapudi; Meenal Shukla; Ravi Alluri; Sergei Merkulov; Keith R McCrae
Journal:  FASEB J       Date:  2016-07-11       Impact factor: 5.191

3.  Zinc chelation promotes streptokinase-induced thrombolysis in vitro.

Authors:  Zihui Wang; Xinge Yu; Yang V Li
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-11-01

4.  Serum stimulation of CCR7 chemotaxis due to coagulation factor XIIa-dependent production of high-molecular-weight kininogen domain 5.

Authors:  Manish P Ponda; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

Review 5.  Cross-talk between the complement and the kinin system in vascular permeability.

Authors:  Fleur Bossi; Ellinor I Peerschke; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Immunol Lett       Date:  2011-07-06       Impact factor: 3.685

6.  Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells.

Authors:  Berhane Ghebrehiwet; Yan Ji; Alisa Valentino; Lina Pednekar; Mahalakshmi Ramadass; David Habiel; Richard R Kew; Kinga H Hosszu; Dennis K Galanakis; Uday Kishore; Ellinor I B Peerschke
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

7.  High molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cells.

Authors:  Dhaval Kolte; Noah Osman; Jia Yang; Zia Shariat-Madar
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

Review 8.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

9.  Extraction and identification of membrane proteins from black widow spider eggs.

Authors:  Si-Ling Fu; Jiang-Lin Li; Jia Chen; Qiu-Ting Wang; Jian-Jun Li; Xian-Chun Wang
Journal:  Dongwuxue Yanjiu       Date:  2015-07-18

10.  Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.

Authors:  Berhane Ghebrehiwet; Jolyon Jesty; Sulan Xu; Rama Vinayagasundaram; Uma Vinayagasundaram; Yan Ji; Alisa Valentino; Kinga K Hosszu; Sally Mathew; Kusumam Joseph; Allen P Kaplan; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2011-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.